Exploring Neurologic Outcomes of Immune Checkpoint Inhibitors in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder

The chapter delves into the impact of immune checkpoint inhibitors on individuals with multiple sclerosis and neuromyelitis optica spectrum disorder, emphasizing potential neurologic adverse events and questioning the safety of this therapy in autoimmune demyelinating disorders.